PDCD1 and cancer: Multiple studies have clarified the mechanism by which PD-1 and PD-L1 inhibit T-cell activation, and it has been shown that the overexpression of PD-L1 in cancer cells is associated with poor prognosis in a wide range of tumor types (21, 22).